NEUGEBOREN EDWARD — SEC Form 4 filings

SEC reporting owner CIK 1320873. 5 Form 4 filings on record with FilingPulse; latest filed 2026-09-21.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2023-12-20 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Grace Therapeutics, Inc. (GRCE)Director44
Matinas BioPharma Holdings, Inc. (MTNB)Director11

Form 4 filings — NEUGEBOREN EDWARD

FiledFormIssuerReported transactionsSource
2026-09-214Grace Therapeutics, Inc. (GRCE)Grant/award (A): 12,200 (derivative) @ $0EDGAR
2026-01-124Grace Therapeutics, Inc. (GRCE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-134Grace Therapeutics, Inc. (GRCE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-024Matinas BioPharma Holdings, Inc. (MTNB)Grant/award (A): 11,600 (derivative) @ $0EDGAR
2023-12-204Acasti Pharma Inc. (ACST)Grant/award (A): 22,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2023-12-20 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1320873 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →